Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 3/20 | 0.50 |
| ▸ | STAT3 | P40763 | 1/20 | 0.50 |
| ▸ | STAT1 | P42224 | 1/20 | 0.50 |
| ▸ | TERT | O14746 | 4/20 | 0.49 |
| ▸ | CYCS | P99999 | 3/20 | 0.49 |
| ▸ | BRAF | P15056 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | DHODH | Q02127 | 1/20 | 0.42 |
| ▸ | PRKCI | P41743 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1640460 | 0.89 | TERT (0.50) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL30925005 | 0.87 | TOP1 (0.57) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL29239611 | 0.87 | TOP1 (0.57) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL1639287 | 0.82 | STAT3 (0.51) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL29405434 | 0.82 | TOP1 (0.64) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL30136 | 0.82 | TOP1 (0.64) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL4266268 | 0.81 | TERT (0.46) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL1640992 | 0.81 | TOP1 (0.54) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL4268731 | 0.81 | TERT (0.46) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL8865508 | 0.81 | TERT (0.46) | TOP1STAT3STAT1TERTCYCS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2493897-A1 | HYDROXY-SUBSTITUTED GOLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS | The University of Hong Kong (CN) | 2012-09-05 | — | — | EP | claimed |
| WO-2011050575-A1 | HYDROXY-SUBSTITUTED GOLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS | THE UNIVERSITY OF HONG KONG (CN) | 2011-05-05 | — | — | WO | claimed |
| US-20110098263-A1 | HYDROXY-SUBSTITUTED COLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS | CHE CHI MING | 2011-04-28 | — | — | US | claimed |
| US-8563712-B2 | Hydroxy-substituted gold(III) porphyrin complexes as histone deacetylase inhibitors | THE UNIVERSITY OF HONG KONG (HK) | 2013-10-22 | — | — | US | disclosed |
| EP-2493897-A1 | HYDROXY-SUBSTITUTED GOLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS | The University of Hong Kong (CN) | 2012-09-05 | — | — | EP | disclosed |
| WO-2011050575-A1 | HYDROXY-SUBSTITUTED GOLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS | THE UNIVERSITY OF HONG KONG (CN) | 2011-05-05 | — | — | WO | disclosed |
| US-20110098263-A1 | HYDROXY-SUBSTITUTED COLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS | CHE CHI MING | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098263-A1 | HYDROXY-SUBSTITUTED COLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS | HDAC1, HDAC8, HDAC3 | TOP1 400/4885STAT3 600/4885STAT1 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.